The CDx System is a combination medical device consisting of the OncoGuide™ OncoScreen™ Plus CDx Kit and the OncoGuide™ ...

Treating small wounds shouldn’t have to mean choosing between comfort and protection. With Dimora PHMB Skin and Wound ...

U.S. Fast Track designation underscores the strength of the alnodesertib clinical data generated to date and the high degree of unmet need in 3L mCRC; CAMBRIDGE, United Kingdom an ...

Palvella Therapeutics Announces Expansion of QTORIN™ Rapamycin’s Development into Clinically Significant Angiokeratomas, a Rare, Chronically Debilitating Lymphatic Disease with No FDA-approved ...

Driving innovation across isotopes, targeting molecules and cancer indications keeps ITM at the forefront of the rapidly evolving radiopharmaceutical industry, ” said Dr. Andrew Cavey, CEO of ITM. “ ...

Cumulative mean change from baseline: -6.08 mg (95% CI: -10.18 mg to -1.98 mg), see graphs below About Monopar Therapeutics ...

Patients begin with a secure online application, followed by an in-depth surgeon consultation. If approved, Elevé provides ...

Widely regarded as arguably the best OTC fat burner and appetite suppressant pill, PhenQ helps users tackle fat loss from ...

Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today highlights emerging scientific evidence linking ...

Synendos successfully completed its Phase 1 clinical program in healthy volunteers, following the pre-clinical development of its lead compound SYT-510, and regulatory approval received from the EMA ...

Following the adjustment of the number of shares and voting rights in circulation, this Shareholder Group, acting in concert, now holds—directly and indirectly—approximately 14.22% of the Company’s ...

Basel, September 24, 2025 – Novartis today announced new data from two Kesimpta ® (ofatumumab) studies in relapsing multiple sclerosis (RMS) that will be presented at the European Committee for ...